ReviewOncoTargets and therapy2022

Targeted Therapy for Locally Advanced or Metastatic Urothelial Cancer (mUC): Therapeutic Potential of Sacituzumab Govitecan.

Mariane S Fontes et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.